http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
BD Promotes Two Senior Executives to Segment Leadership Roles
-
BD to Present at the Wells Fargo 2022 Healthcare Conference
-
BD, Accelerate Diagnostics Announce Global Commercial Collaboration
-
BD, Labcorp Collaborate to Develop Flow Cytometry-Based Companion Diagnostics for Matching Patients with Treatments
-
BD, Direct Relief and National Association of Community Health Centers Advance Health Equity in the U.S. with $1 Million Grant
-
BD REPORTS THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS
-
Becton Dickinson (BDX) Acquires MedKeeper
-
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software
-
Becton Dickinson (BDX) and CerTest Biotec Launch Monkeypox Test
-
BD, CerTest Biotec Announce Commercial Launch of Monkeypox Test
-
BD Board Declares Dividend
-
BD Earns Recognition as a Best Place to Work for Disability Inclusion
-
Becton Dickinson (BDX) Completes Acquisition of Parata Systems
-
BD Completes Acquisition of Parata Systems
-
BD TO ANNOUNCE FINANCIAL RESULTS FOR ITS THIRD QUARTER OF FISCAL 2022
-
BD Names Rishi Grover as Chief Integrated Supply Chain Officer
-
BD Issues 2021 ESG Report
-
BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus
-
Pre-Open Stock Movers 06/24: Zendesk Surges on Surprise Deal; LendingTree Falls on Lower Outlook (More...)
-
Becton Dickinson (BDX) Announces Voluntary Recall on Intraosseous Products
-
BD Announces Voluntary Recall on Intraosseous Products
-
BD Collaborates with Mayo Clinic Platform, Leveraging Real-World Clinical Data to Improve Post-Market Device Surveillance, Drive Innovation for Patient Care
-
Becton Dickinson (BDX) and CerTest Biotec Collaborate for Molecular Diagnostic Test for Monkeypox
-
CerTest Biotec and BD Announce Collaboration on Molecular Diagnostic Test for Monkeypox
-
BD Names Simon Campion as Medical Segment President
-
Becton Dickinson (BDX) Acquires Parata Systems for $1.525B Cash
-
BD TO ACQUIRE PARATA SYSTEMS TO ENTER NEW PHARMACY AUTOMATION SOLUTIONS MARKET
-
BD Unveils World's First Spectral Cell Sorter with High-Speed Imaging Technology that Sorts Cells Based on Visual Characteristics
-
BD to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
-
Becton Dickinson (BDX) Announces Launch of Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the U.S.
-
BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the U.S.
-
Babson, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings
-
BD REPORTS SECOND QUARTER FISCAL 2022 FINANCIAL RESULTS
-
BD Announces Inaugural Members of Scientific Advisory Board
-
BD to Present at the BofA Securities 2022 Healthcare Conference
-
BD Board Declares Dividend
-
BD Named to Forbes' 2022 List of Best Employers for Diversity
-
New BD Reagents Enable Researchers to Break Through Resolution Boundaries in Flow Cytometry
-
BD Forms Sustainable Medical Technology Institute to Reduce the Environmental Impact of its Product Portfolio
-
BD TO ANNOUNCE FINANCIAL RESULTS FOR ITS SECOND QUARTER OF FISCAL 2022
-
Becton Dickinson (BDX) Announces Completion of Embecta Corp. (EMBC) Spinoff
-
BD Announces Completion of Embecta Corp. Spinoff
-
Alberto Mas Announces Intent to Retire from BD at End of Fiscal Year
-
BD Announces Early Tender Results for Cash Tender Offers by Morgan Stanley & Co. LL
-
BD Named One of America's Most Trusted Companies by Newsweek
-
BD Provides Update Regarding the Planned Spinoff of Embecta Corp.
-
BD Announces Cash Tender Offers by Morgan Stanley & Co. LLC
-
Becton Dickinson (BDX) Appoints William Brown to its Board
-
BD Names William 'Bill' Brown to Board of Directors
-
BD to Present at the Cowen 42nd Annual Health Care Conference
